We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 4.76% | 1.10 | 1.00 | 1.10 | 1.05 | 1.05 | 1.05 | 397,039 | 16:35:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Components, Nec | 1.57M | -2.29M | -0.0128 | -0.82 | 1.88M |
From Apr 2019 to Apr 2024
TIDMMSYS
RNS Number : 8666B
Microsaic Systems plc
07 April 2017
7 April 2017
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Microsaic signs amended agreement with Global Partner
Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it has signed an amendment to its Research Collaboration Agreement with a long standing global partner. The amended agreement is a precursor to future collaboration in the area of bio-processing.
Interim Chairman, Eric Yeatman commented:
"We are delighted to sign this agreement with one of the foremost players in the global market for scientific instrumentation, which is in line with the Company's strategy to focus on application areas in biopharma."
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
Enquiries: Microsaic Systems plc Jim Ramage, CEO Bevan Metcalf, FD +44 (0) 1483 751577 N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Liz Yong +44 (0)20 7496 3000 Citigate Dewe Rogerson (Financial PR) Mark Swallow, Marine Perrier +44 (0)20 7282 2948/1068
About Microsaic Systems
Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.
Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.
The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.
The Microsaic 4000 MiD(R), single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.
Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).
www.microsaic.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRBCGDSXBGBGRL
(END) Dow Jones Newswires
April 07, 2017 02:00 ET (06:00 GMT)
1 Year Microsaic Systems Chart |
1 Month Microsaic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
